ClinicalTrials.gg
CompletedNCT00963651Updated Jul 24, 2013

GE Healthcare VolumeRAD Lung Nodule Detection Study

An observational study in Pulmonary Nodule, Solitary and Multiple Pulmonary Nodules, sponsored by American College of Radiology - Image Metrix. Completed at 4 sites in 2 countries. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-07-24.

Sponsored by American College of Radiology - Image Metrix · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
187
Ages
18 Years and older
Sex
All
01

Study summary

To perform a multiple reader, multiple case (MRMC) observer study assessing the detection performance of VolumeRAD tomosynthesis of the chest in detecting lung nodules.

Read the detailed description

Digital tomosynthesis is a form of limited angle tomography that creates a series of section images using a conventional x-ray tube and generator, a digital detector, and appropriate reconstruction software. It creates section images from a series of projection images acquired as the x-ray tube moves along a prescribed path. Because tomosynthesis can minimize the visual presence of overlying anatomy - the ribs, for example - it has the potential to improve the detection of lesions such as pulmonary nodules when compared with conventional chest radiography.

The primary aim of this study is to determine whether the use of VolumeRAD tomosynthesis, in addition to CxR, increases physician accuracy in the detection of lung nodules between 3mm and 20mm in diameter when compared to conventional posterior-anterior (PA) and lateral (LAT) chest radiography (CxR). This aim will be addressed by measuring free-response performance of experienced (with VolumeRAD), blinded expert readers' detection performance. Specifically, we will compare detection performance, as measured by the area under the alternative free response receiver operating characteristic (AFROC) curve, among readers viewing PA and LAT chest X-rays versus VolumeRAD tomosynthesis. The nodule will be the unit of analysis.

02

Conditions studied

  • Pulmonary Nodule, Solitary
  • Multiple Pulmonary Nodules

Keywords

  • Pulmonary nodule, solitary
  • Multiple pulmonary nodules
03

In context

Solitary Pulmonary Nodule

88 studies on the registry are indexed under Solitary Pulmonary Nodule; 19 are open to participants now.

This study's enrollment of 187 is below the median of 401 across 41 observational studies indexed under Solitary Pulmonary Nodule.

Browse Solitary Pulmonary Nodule studies →

Lead sponsor

American College of Radiology - Image Metrix is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Participants will include those referred for x-ray computed tomography (CT) of the chest for suspicion of a pulmonary nodule or other unrelated reasons.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Scheduled for chest CT as part of their needed medical care;
  • If available, individuals who have had previous imaging to suggest they fulfill the needs of the study;
  • 18 years of age, or older;
  • In good enough physical condition to stand motionless and hold their breath during the image acquisition procedures.

Exclusion criteria

Exclusion Criteria:

  • Children under 18 years of age;
  • Women who are pregnant or who suspect they may be pregnant;
  • Individuals who on previous imaging are shown to have objects in or around the lungs that might produce substantial artifacts that would obscure pulmonary nodules;
  • Individuals who on recent imaging had active lung or pleural disease that would obscure pulmonary nodules;
  • Individuals with more than 5 pulmonary nodules between 5mm and 20mm in diameter in either right or left lung.
  • Individuals suspected to have more than 15 total nodules between 3mm and 20mm. NOTE that up to 20 nodules between 3mm and 20mm will be allowed in the final study sample.
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
187 participants (actual)

Groups and cohorts

  • Suspicion of pulmonary nodules

    Eligible participants will include those referred for x-ray computed tomography (CT) of the chest for suspicion of a pulmonary nodule or other unrelated reasons.

    Device: Chest tomosynthesis and X-ray

Interventions

  • DeviceChest tomosynthesis and X-ray

    VolumeRAD tomosynthesis; Conventional Chest X-ray; Dual energy (bone and soft tissue PA chest images)

06

What researchers measure

Primary outcomes

  1. Multi-reader, multi-case Receiver Operating Characteristics (ROC) methodology.

    The primary objective of this study is to determine if the use of VolumeRAD tomosynthesis increases the accuracy of the detection of lung nodules between 3mm and 20mm in diameter when compared to conventional PA and lateral chest radiography alone.

    Time frame: Post accrual of 210 participants

Secondary outcomes

  1. Actionability classification accuracy of all modalities

    Time frame: Multipe reader, multiple case reader study

07

Study locations

4 sites
  • University of Michigan
    Ann Arbor, Michigan 48103, United States
  • Duke University Medical Center
    Durham, North Carolina 27705, United States
  • University of Washington Medical Center
    Seattle, Washington 98195, United States
  • Sahlgrenska University Hospital
    Gothenburg, SE-413 45, Sweden
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Aug 2009, a primary completion of Jul 2013 and a completion of Jul 2013. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 20, 2009
First posted
Aug 21, 2009
Start
Aug 2009
Primary completionActual
Jul 2013
CompletionActual
Jul 2013
Last update
Jul 24, 2013
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 24, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00963651
Lead sponsor
American College of Radiology - Image Metrix
Collaborators
GE Healthcare
Responsible party
Sponsor
First posted
Aug 21, 2009
Start date
Aug 2009
Primary completion
Jul 2013
Completion
Jul 2013
Last update
Jul 24, 2013

Study contacts

James Dobbins, MD
principal investigator · Duke University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion